Effect of long-term postoperative interferon therapy on intrahepatic recurrence and survival rate after resection of hepatitis C virus-related hepatocellular carcinoma (Q42991471)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 2005

Language	Label	Description	Also known as
English	Effect of long-term postoperative interferon therapy on intrahepatic recurrence and survival rate after resection of hepatitis C virus-related hepatocellular carcinoma	scientific article published on January 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Effect of long-term postoperative interferon therapy on intrahepatic recurrence and survival rate after resection of hepatitis C virus-related hepatocellular carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Shuhei Nishiguchi

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Akihiro Tamori

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Shoji Kubo

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

48

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

71-75

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Effects of continuous hepatitis with persistent hepatitis C viremia on outcome after resection of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1159%2F000082098

21 January 2018

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

1 reference

https://api.crossref.org/works/10.1159%2F000082098

21 January 2018

Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1159%2F000082098

21 January 2018

Clinicopathological criteria for multicentricity of hepatocellular carcinoma and risk factors for such carcinogenesis.

1 reference

https://api.crossref.org/works/10.1159%2F000082098

21 January 2018

Relationship between multicentric occurrence of hepatocellular carcinoma and histology of noncancerous hepatic tissue in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1159%2F000082098

21 January 2018

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy

1 reference

https://api.crossref.org/works/10.1159%2F000082098

21 January 2018

Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer

1 reference

https://api.crossref.org/works/10.1159%2F000082098

21 January 2018

Recombinant interferon-alpha in inoperable hepatocellular carcinoma: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1159%2F000082098

21 January 2018

Prognostic factors after recurrence of resected hepatocellular carcinoma associated with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1159%2F000082098

21 January 2018

Determinants of outcome of compensated hepatitis C virus-related cirrhosis

1 reference

https://api.crossref.org/works/10.1159%2F000082098

21 January 2018

Identifiers

10.1159/000082098

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42991471&oldid=2127487070"